Similarly, in prostate cancer (PCa), highly expressed MCM3AP-AS1 facilitates cancer cell progression by recruiting DNMT1/DNMT3 to the NPY1R promoter, which downregulates NPY1R expression and activates the MAPK pathway [30]. This evidence concerns the gene NPY1R and prostate carcinoma.